Xin Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xin Xu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Chen Wu
College of Life Sciences, Hebei University, Baoding, China
1 shared publication - Congwen Gao
Guangdong Key Laboratory for Genome Stability & Disease Prevention and Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, 518060, Shenzhen, Guangdong, China
1 shared publication Mengyuan Li
College of Life Sciences, Hebei University, Baoding, China
1 shared publication- Shun Zhang
Affiliated Hospital of Hebei University, BaoDing, China
1 shared publication - XiaoRui Sun
College of Life Sciences, Hebei University, Baoding, China
1 shared publication Xinhua Zhao
College of Life Sciences, Hebei University, Baoding, China
1 shared publication
Latest Publications
- 25 July 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (9) , e56230
FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1
Fibrillarin (FBL) is a highly conserved nucleolar methyltransferase responsible for methylation of ribosomal RNA and proteins. Here, we reveal a role for FBL in DNA damage response and its impact on cancer proliferation and sensitivity to DNA-damaging agents. FBL is highly expressed in various cancers and correlates with poor survival outcomes in cancer patients. Knockdown of FBL sensitizes tumor cells and xenografts to DNA crosslinking agents, and leads to homologous recombination-mediated DNA repair defects. We identify Y-box-binding protein-1 (YBX1) as a key interacting partner of FBL, and FBL increases the nuclear accumulation of YBX1 in response to DNA damage. We show that FBL promotes the expression of BRCA1 by increasing the binding of YBX1 to the BRCA1 promoter. Our study sheds light on the regulatory mechanism of FBL in tumorigenesis and DNA damage response, providing potential therapeutic targets to overcome chemoresistance in cancer.
- 25 July 2023
- Published by Springer Nature in EMBO Reports
- Vol. 24 (9) , e56230
FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1
Fibrillarin (FBL) is a highly conserved nucleolar methyltransferase responsible for methylation of ribosomal RNA and proteins. Here, we reveal a role for FBL in DNA damage response and its impact on cancer proliferation and sensitivity to DNA-damaging agents. FBL is highly expressed in various cancers and correlates with poor survival outcomes in cancer patients. Knockdown of FBL sensitizes tumor cells and xenografts to DNA crosslinking agents, and leads to homologous recombination-mediated DNA repair defects. We identify Y-box-binding protein-1 (YBX1) as a key interacting partner of FBL, and FBL increases the nuclear accumulation of YBX1 in response to DNA damage. We show that FBL promotes the expression of BRCA1 by increasing the binding of YBX1 to the BRCA1 promoter. Our study sheds light on the regulatory mechanism of FBL in tumorigenesis and DNA damage response, providing potential therapeutic targets to overcome chemoresistance in cancer.